comparison of cardiac function in young patients with thalassemia intermedia and healthy individuals using echocardiography method

Authors

nouri nm

naderi m

emamdadi a

fadaie m

abstract

background: cardiac dysfunction due to chronic anemia and hemosiderosis are the major causes of death among patients with thalassemia intermedia. this study was performed to compare the cardiac function in thalassemia intermedia patients with normal subjects by means of echocardiography. materials and methods: this was a case-control study performed on 22 patients affected by thalassemia intermedia in the age range of 8 to 25 years treated in pediatric ward of ali ibn-e abi talib teaching hospital, zahedan, , south east of iran, from january 2007 until july 2008. there was no sign of cardiac involvement by physical examination, chest x-ray and ecg in these patients. the control group was selected from normal individuals and was matched by sex and age (66 healthy individuals). echocardiographic parameters were measured in patient and control groups. results: findings of this study showed that the mean age of patients was years and the mean age of the control group was years (p=0.6). the mean left ventricular myocardial performance index (p=0.001), left ventricular mass index (p=0.0001) interventricular septal dimension in diastole (p=0.002), left ventricular posterior wall thickness in diastole (p=0.001), interventricular septal dimension in systole (p=0.01), left ventricular posterior wall dimension in systole (p=0.003), aortic pre-ejection period/ejection time (p=0.009), ejection fraction (p=0.019), fractional shortening (p=0.04), left ventricular isovolumetric contraction time (p=0.0001), left ventricular isovolumetric relaxation time (p=0.0001), right ventricular myocardial performance index (p=0.0001), and isovolumetric relaxation time (p=0.0001) were statistically significantly different between patients and controls. other echocardiographic parameters did not show a statistically significant difference between patients and controls. conclusion: the results of the present study show that cardiac systolic and diastolic function in patients with thalassemia intermedia is compromised in comparison with the control group. keywords: thalassemia intermedia, echocardiography, cardiac function

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Comparison of Cardiac Function in Young Patients with Thalassemia Intermedia and Healthy Individuals Using Echocardiography Method

Background: Cardiac dysfunction due to chronic anemia and hemosiderosis are the major causes of death among patients with thalassemia intermedia. This study was performed to compare the cardiac function in thalassemia intermedia patients with normal subjects by means of echocardiography. Materials and Methods: This was a case-control study performed on 22 patients affected by thalassemia int...

full text

Evaluation of Cardiac Function in Patients with Thalassemia Intermedia

Abstract Background Thalassemia intermedia is a variety of beta thalassemia which shows clinical symptoms somewhere between asymptomatic carriers and thalassemia major. Cardiac dysfunctions due to chronic anemia and hemosiderosis are the major causes of death in these patients. The purpose of this study is to evaluate cardiac function in these patients by echocardiography. Materials and Met...

full text

Evaluation of Cardiac Function in Patients with Thalassemia Intermedia

BACKGROUND Thalassemia intermedia is a variety of beta thalassemia which shows clinical symptoms somewhere between asymptomatic carriers and thalassemia major. Cardiac dysfunctions due to chronic anemia and hemosiderosis are the major causes of death in these patients. The purpose of this study is to evaluate cardiac function in these patients by echocardiography. MATERIALS AND METHODS This c...

full text

Diagnostic Value of NT-pro BNP Biomarker and Echocardiography in Cardiac Involvements in Beta-thalassemia Patients

Background N-terminal pro–B-type natriuretic peptide (NT-proBNP) is a marker to evaluate the cardiac involvement in thalassemia. We aimed to evaluate conventional and tissue Doppler echocardiography findings and its relation to plasma NT-pro BNP, Ferritin and Iron levels in beta-thalassemia patients. Materials and Methods This study performed on 164 participants equal of major beta- thalassemi...

full text

Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea

Hydroxyurea (HU) has been successfully used in patients with β-thalassemia intermedia (β-TI). We aimed to evaluate the effect of the long-term use of HU on thyroid function in patients with β-TI. Seventy-five patients with β-TI aged≥11 years and taking HU were randomly selected during 2010 in southern Iran. Thirty-one patients with β-TI without HU were considered as a control group. Serum level...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of blood and cancer

جلد ۴، شماره ۴، صفحات ۱۵۷-۱۶۱

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023